Most Recent
Norbrook appeals approval of Bayer’s animal antiseptic patent
Appeals 2020-07-24 10:45 pm By Cat Fredenburgh

Veterinary pharmaceutical company Norbrook Laboratories has filed court proceedings after a delegate of IP Australia tossed its opposition to a patent by Bayer New Zealand for a bovine antiseptic treatment.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Lorna Jane fined over anti-virus activewear claims
Healthcare 2020-07-17 9:35 pm By Cat Fredenburgh

Brisbane clothing company Lorna Jane has been fined almost $40,000 for implying that its ‘anti-virus activewear’ prevents against infectious diseases such as COVID-19.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Medibank ordered to pay $5M for misleading members over coverage for critical surgery
Competition & Consumer Protection 2020-07-16 1:20 pm By Christine Caulfield

A judge has ordered private health insurer Medibank to pay $5 million in penalties for rejecting the claims of hundreds of members who were entitled to coverage for critical medical procedures, including spinal surgery.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Lead applicant in horse vaccine class action told to ‘put up or shut up’
Class Actions 2020-07-07 9:03 pm By Miklos Bolza

Global animal health company Zoetis has told the lead applicants in a class action over horse vaccines to “put up or shut up” and produce evidence disclosing an alleged scientific link between the hendra virus vaccine and certain alleged adverse side effects.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Breast implants class action targets ‘incompetent’ surgeons
Class Actions 2020-07-07 7:25 pm By Miklos Bolza

The lead applicants in a class action against The Cosmetic Institute have added 11 cosmetic surgeons to the lawsuit, alleging they conducted breast augmentation surgery in an “incompetent” manner.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mylan loses Lipidil appeal, despite court finding proof of intention not needed for Swiss-style claims
Intellectual Property 2020-07-03 5:27 pm By Miklos Bolza

Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pelvic mesh judge calls for ‘someone who understands how to plead a representative proceeding’
Product Liability 2020-07-02 8:52 pm By Alison Eveleigh

A judge has adjourned an interlocutory application because of deficient pleadings in a class action brought against three medical device manufacturers and a former doctor on behalf of thousands of women who claim to have suffered lifelong complications from pelvic mesh implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer defeats Norbrook opposition to animal antiseptic patent
Intellectual Property 2020-07-02 4:03 pm By Miklos Bolza

A delegate of IP Australia has tossed opposition by veterinary pharmaceutical company Norbrook Laboratories to a patent by rival animal health specialist Bayer New Zealand for a bovine antiseptic treatment.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Law firm investigates class action against nursing home over COVID-19 outbreak
COVID-19 2020-07-01 6:09 pm By Cat Fredenburgh

The company that operates the Newmarch House nursing home in Sydney is facing a possible class action after a coronavirus outbreak at the facility resulted in the deaths of 19 residents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Janssen to expand patent case against Juno over generic HIV drug
Intellectual Property 2020-07-01 4:40 pm By Miklos Bolza

Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno’s plans to launch a generic version of the drug threaten another one of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?